Skip to main navigation Skip to search Skip to main content

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study

  • Avner Ehrlich
  • , Konstantinos Ioannidis
  • , Makram Nasar
  • , Ismaeel Abu Alkian
  • , Yuval Daskal
  • , Nofar Atari
  • , Limor Kliker
  • , Nir Rainy
  • , Matan Hofree
  • , Sigal Shafran Tikva
  • , Inbal Houri
  • , Arrigo Cicero
  • , Chiara Pavanello
  • , Cesare R. Sirtori
  • , Jordana B. Cohen
  • , Julio A. Chirinos
  • , Lisa Deutsch
  • , Merav Cohen
  • , Amichai Gottlieb
  • , Adina Bar-Chaim
    • Oren Shibolet, Michal Mandelboim, Shlomo L. Maayan, Yaakov Nahmias
  • Hebrew University of Jerusalem
  • Barzilai Medical Center
  • Ministry of Health, Israel
  • Shamir (Assaf Harofeh) Medical Center
  • Broad Institute
  • Jerusalem College of Technology
  • Tel Aviv Sourasky Medical Center
  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola – Malpighi
  • University of Milan
  • Asst Grande Ospedale Metropolitano Niguarda
  • University of Pennsylvania
  • BioStats Statistical Consulting Ltd
  • Tel Aviv University

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology